Clinical Excellence Research Center
The first university-based research center exclusively dedicated to discovering, testing, and evaluating cost-saving innovations in clinically excellent care. Our research seeks more affordable ways to deliver better care for conditions consuming the bulk of the country's healthcare spending.
CERC's Response to COVID-19
The Covid-19 crisis is challenging CERC’s faculty, scholars, and fellows to rapidly develop innovations that lower the cost of clinically excellent infectious disease care. Additionally, our Partnership in AI-Assisted Care, with faculty and graduate students from the computer science department, is moving ahead with computer vision applications to ease the burden on clinicians striving to deliver exceptional COVID care to ICU patients.
A Message From The Director
"Federal creditworthiness and therefore American prosperity now hinge on continuously attaining better health with less health spending. By rapidly mobilizing emerging science and technology from engineering, management, and medicine, the Clinical Excellence Research Center will enable Stanford to help solve a seemingly intractable national challenge."
- Arnold Milstein, MD, MPH
Dr. Milstein founded CERC after two decades of improving healthcare value in the private sector and advising the White House and Congress. He is now training America's next generation of healthcare innovators to remove wasteful and dangerous inefficiencies that ail the U.S. health-care system.
CERC NEWS & PUBLICATIONS
Journal of the American Medical Informatics Association, July 27, 2020
As part of CERC’s Partnership for AI-Assisted Care, researchers concluded a computer vision algorithm was equal to human observation in detecting adherence to hand hygiene protocol.
Medpage Today, July 19, 2020
CERC’s Robert Kaplan and David Scheinker highlight the need for a coordinated national research strategy to reduce confusion
Health Affairs, July 9, 2020
CERC Adjunct Professor Amit Kaushal writes that we need ensure tracing operations are effective while quaranting as few people as possible.
American Heart Journal, July 2, 2020
Kevin Schulman reports that list price increases and payments have been growing disproportionally to manufacturer net income despite widespread public concern about rising outpatient prescription drug prices
NEJM , July 1 2020
While it may be tempting to blame the plunge in hospitals’ profitability on the COVID-19 pandemic, the problem can be linked to hospital business strategies that began two decades ago, according to researchers at Stanford University.